These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15068826)

  • 1. Kava kava: examining new reports of toxicity.
    Clouatre DL
    Toxicol Lett; 2004 Apr; 150(1):85-96. PubMed ID: 15068826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ethanol in kava hepatotoxicity.
    Li XZ; Ramzan I
    Phytother Res; 2010 Apr; 24(4):475-80. PubMed ID: 19943335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava consumption and its health effects.
    Gounder R
    Pac Health Dialog; 2006 Sep; 13(2):131-5. PubMed ID: 18181402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.
    Teschke R; Qiu SX; Xuan TD; Lebot V
    Phytother Res; 2011 Sep; 25(9):1263-74. PubMed ID: 21442674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
    Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
    Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constituents in kava extracts potentially involved in hepatotoxicity: a review.
    Olsen LR; Grillo MP; Skonberg C
    Chem Res Toxicol; 2011 Jul; 24(7):992-1002. PubMed ID: 21506562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats.
    Lim ST; Dragull K; Tang CS; Bittenbender HC; Efird JT; Nerurkar PV
    Toxicol Sci; 2007 May; 97(1):214-21. PubMed ID: 17329236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum.
    Tugcu G; Kırmızıbekmez H; Aydın A
    Food Chem Toxicol; 2020 Nov; 145():111663. PubMed ID: 32827561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and in vitro toxicity analysis of a supercritical fluid extract of Kava kava (Piper methysticum).
    Petersen GE; Tang Y; Fields C
    J Ethnopharmacol; 2019 May; 235():301-308. PubMed ID: 30710733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kava hepatotoxicity: pathogenetic aspects and prospective considerations.
    Teschke R
    Liver Int; 2010 Oct; 30(9):1270-9. PubMed ID: 20630022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
    Zou L; Harkey MR; Henderson GL
    Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats.
    Yamazaki Y; Hashida H; Arita A; Hamaguchi K; Shimura F
    Food Chem Toxicol; 2008 Dec; 46(12):3732-8. PubMed ID: 18930106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kava as a Clinical Nutrient: Promises and Challenges.
    Bian T; Corral P; Wang Y; Botello J; Kingston R; Daniels T; Salloum RG; Johnston E; Huo Z; Lu J; Liu AC; Xing C
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33027883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tradition and toxicity: evidential cultures in the kava safety debate.
    Baker JD
    Soc Stud Sci; 2011 Jun; 41(3):361-84. PubMed ID: 21879526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition and biological activity of traditional and commercial kava extracts.
    Côté CS; Kor C; Cohen J; Auclair K
    Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation and the use of KAVA: Case report.
    Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR
    Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does inflammation play a role in kava hepatotoxicity?
    Zhang LY; Rowe A; Ramzan I
    Phytother Res; 2011 Apr; 25(4):629-30. PubMed ID: 20842679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kava lactones and the kava-kava controversy.
    Whitton PA; Lau A; Salisbury A; Whitehouse J; Evans CS
    Phytochemistry; 2003 Oct; 64(3):673-9. PubMed ID: 13679089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contaminant hepatotoxins as culprits for kava hepatotoxicity--fact or fiction?
    Teschke R; Sarris J; Lebot V
    Phytother Res; 2013 Mar; 27(3):472-4. PubMed ID: 22585547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.